Incitec Pivot (ASX:IPL) is reported to have chosen the Indonesian state-owned company Pupuk Kaltim as the preferred buyer of its significant Australian fertilisers business. Sydney brokers and analysts say the sale could end up at a price of around $1.5 billion, but it may bring on a showdown with rural politicians and farmers in parts […]
Fertiliser frenzy: Incitec Pivot to partner with Pupuk Kaltim Read More »
Little Green Pharma (ASX:LGP) has announced that its Desert Flame high THC (20%) medicinal cannabis flower product has received Marketing Authorisation in Poland. This marks a significant milestone for the company, providing new opportunities in the rapidly growing medicinal cannabis market in Poland. In Poland, Marketing Authorisations are the exclusive pathway for the supply of
Poland green lights Little Green Pharma Read More »
Mark Freeman, CEO and David Grace, Portfolio Manager discuss the FY23 full year results of Australian Foundation Investment Company (ASX:AFI).
Australian Foundation Investment Company (ASX:AFI) FY23 full year results Read More »
Mark Freeman, CEO and Brett McNeill, Portfolio Manager discuss the FY23 full year results of Djerriwarrh Investments (ASX:DJW).
Djerriwarrh Investments (ASX:DJW) FY23 full year results Read More »
Tamboran Resources (ASX:TBN) has signed four separate non-binding Letters of Intent with Origin, AGL, EnergyAustralia and Shell Energy Australia to potentially purchase gas from Tamboran’s low-reservoir Beetaloo Basin gas assets for a period of up to 10 – 15 years. In response, Managing Director and CEO, Joel Riddle, said: “The initial interest from key East
Stocks of the Hour: Tamboran Res, Sayona Mining, BCAL Diagnostics, Nova Eye Medical Read More »
Mark Freeman, CEO and Portfolio Manager of AMCIL (ASX:AMH), discusses FY23 full year results.
AMCIL (ASX:AMH) FY23 full year results Read More »
Mark Freeman, CEO and Kieran Kennedy, Portfolio Manager discuss the FY23 full year results of Mirrabooka Investments (ASX:MIR).
Mirrabooka Investments (ASX:MIR) FY23 full year results Read More »
According to UBS analysts, Suncorp (ASX:SUN), Hub24 (ASX:HUB), GQG Partners, and Magellan (ASX:MFG) are potential sources of upside in the upcoming reporting season. They believe that Medibank (ASX:MPL) and NIB (ASX:NHF) are likely to perform well, benefiting from low claims, solid participation, and strong non-resident trends. The insurance subsector in the Australian Financial Services is
ASX down 0.7% at noon: UBS analysts forecast upside for health insurers Read More »
02 Aug 2023 – The S&P 500 fell to start August, as investors navigated a raft of corporate earnings reports and assessed a fresh batch of economic data.
More corporate earnings released, copper surges on Chinese optimism Read More »
China’s investments in metals and mining overseas are set to hit a record high this year, as the nation strives to secure vital resources and maintain its position as the world’s leading producer of electric vehicles, batteries, solar panels, and wind turbines. In the first half of this year, Chinese investments and new contracts in
China’s mining investments reach record high amid green tech push Read More »
